Sharyn Thomas

1.1k total citations
15 papers, 754 citations indexed

About

Sharyn Thomas is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Sharyn Thomas has authored 15 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 12 papers in Immunology and 6 papers in Genetics. Recurrent topics in Sharyn Thomas's work include CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Sharyn Thomas is often cited by papers focused on CAR-T cell therapy research (12 papers), Immune Cell Function and Interaction (8 papers) and Immunotherapy and Immune Responses (6 papers). Sharyn Thomas collaborates with scholars based in United Kingdom, United States and Netherlands. Sharyn Thomas's co-authors include Hans J. Stauss, Emma Morris, Shao‐An Xue, Steve Patterson, Ian Teo, Sunil Shaunak, Elisabetta Gianasi, Kamiar Mireskandari, Ruth Duncan and Peng T. Khaw and has published in prestigious journals such as Nature Communications, Blood and Nature Biotechnology.

In The Last Decade

Sharyn Thomas

15 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sharyn Thomas United Kingdom	13	438	355	265	176	100	15	754
Coralie M. Backlund United States	13	199 0.5×	309 0.9×	329 1.2×	71 0.4×	132 1.3×	18	663
Huizi Sha China	17	401 0.9×	277 0.8×	577 2.2×	123 0.7×	309 3.1×	41	1.1k
Mattia Matasci Switzerland	18	218 0.5×	148 0.4×	602 2.3×	244 1.4×	40 0.4×	37	913
Sarah Nietzer Germany	11	344 0.8×	115 0.3×	162 0.6×	50 0.3×	213 2.1×	20	604
Parisa Yousefpour United States	10	147 0.3×	169 0.5×	309 1.2×	83 0.5×	168 1.7×	18	655
Fabio Turatti Italy	9	149 0.3×	75 0.2×	191 0.7×	42 0.2×	69 0.7×	9	468
Cornelia Marty Switzerland	12	284 0.6×	465 1.3×	825 3.1×	132 0.8×	143 1.4×	12	1.3k
Andrew Satterlee United States	13	200 0.5×	161 0.5×	628 2.4×	113 0.6×	425 4.3×	29	1.2k
Alessio Malfanti Italy	18	163 0.4×	217 0.6×	369 1.4×	61 0.3×	321 3.2×	40	918
Ursula Pertl United States	11	288 0.7×	403 1.1×	374 1.4×	115 0.7×	56 0.6×	14	808

Countries citing papers authored by Sharyn Thomas

Since Specialization

Citations

This map shows the geographic impact of Sharyn Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharyn Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharyn Thomas more than expected).

Fields of papers citing papers by Sharyn Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharyn Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharyn Thomas. The network helps show where Sharyn Thomas may publish in the future.

Co-authorship network of co-authors of Sharyn Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Sharyn Thomas. A scholar is included among the top collaborators of Sharyn Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharyn Thomas. Sharyn Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Thomas, Sharyn, et al.. (2024). Exploitation of CD3ζ to enhance TCR expression levels and antigen-specific T cell function. Frontiers in Immunology. 15. 1386132–1386132. 1 indexed citations

Thomas, Sharyn, et al.. (2023). Modifications outside CDR1, 2 and 3 of the TCR variable β domain increase TCR expression and antigen-specific function. Frontiers in Immunology. 14. 1148890–1148890. 1 indexed citations

Holler, Angelika, et al.. (2022). Forced Fox-P3 expression can improve the safety and antigen-specific function of engineered regulatory T cells. Journal of Autoimmunity. 132. 102888–102888. 15 indexed citations

Thomas, Sharyn, Fiyaz Mohammed, Rogier M. Reijmers, et al.. (2019). Framework engineering to produce dominant T cell receptors with enhanced antigen-specific function. Nature Communications. 10(1). 4451–4451. 43 indexed citations

Wright, David J., et al.. (2018). Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2. Frontiers in Immunology. 9. 2595–2595. 22 indexed citations

Thomas, Sharyn, Dan Blat, Galit Denkberg, et al.. (2014). Functional Comparison of Engineered T Cells Carrying a Native TCR versus TCR-like Antibody–Based Chimeric Antigen Receptors Indicates Affinity/Avidity Thresholds. The Journal of Immunology. 193(11). 5733–5743. 103 indexed citations

Xue, Shao‐An, Liquan Gao, Maryam Ahmadi, et al.. (2012). Human MHC Class I-restricted high avidity CD4⁺T cells generated by co-transfer of TCR and CD8 mediate efficient tumor rejection in vivo. OncoImmunology. 2(1). e22590–e22590. 35 indexed citations

Thomas, Sharyn, Shao‐An Xue, Charles R. M. Bangham, et al.. (2011). Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. Blood. 118(2). 319–329. 82 indexed citations

Thomas, Sharyn, Hans J. Stauss, & Emma Morris. (2010). Molecular immunology lessons from therapeutic T‐cell receptor gene transfer. Immunology. 129(2). 170–177. 42 indexed citations

10.

Thomas, Sharyn, Liquan Gao, Roberto Dina, et al.. (2009). IL15 Can Reverse the Unresponsiveness of Wilms' Tumor Antigen-Specific CTL in Patients with Prostate Cancer. Clinical Cancer Research. 15(4). 1145–1154. 17 indexed citations

11.

Thomas, Sharyn, Shao‐An Xue, Michela Cesco-Gaspere, et al.. (2007). Targeting the Wilms Tumor Antigen 1 by TCR Gene Transfer: TCR Variants Improve Tetramer Binding but Not the Function of Gene Modified Human T Cells. The Journal of Immunology. 179(9). 5803–5810. 66 indexed citations

12.

Stauss, Hans J., Sharyn Thomas, Michela Cesco-Gaspere, et al.. (2007). WT1-specific T cell receptor gene therapy: Improving TCR function in transduced T cells. Blood Cells Molecules and Diseases. 40(1). 113–116. 43 indexed citations

13.

Stauss, Hans J., Michela Cesco-Gaspere, Sharyn Thomas, et al.. (2007). Monoclonal T-Cell Receptors: New Reagents for Cancer Therapy. Molecular Therapy. 15(10). 1744–1750. 40 indexed citations

14.

Thomas, Sharyn, Daniel P. Hart, Shao‐An Xue, Michela Cesco-Gaspere, & Hans J. Stauss. (2007). T-cell receptor gene therapy for cancer: the progress to date and future objectives. Expert Opinion on Biological Therapy. 7(8). 1207–1218. 16 indexed citations

15.

Shaunak, Sunil, Sharyn Thomas, Elisabetta Gianasi, et al.. (2004). Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation. Nature Biotechnology. 22(8). 977–984. 228 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact